Ir al contenido
Células endoteliales de la vena safena humana (HSVEC)
Pañuelo de papel
Saphenous vein
Enfermedad
Normal saphenous vein endothelium (primary cells; non-tumorigenic)
Lugar de metástasis
Not applicable (normal, non-tumorigenic primary cell)
Sinónimos
HSaVEC, HSVEC, Human saphenous vein endothelial cells, provitro 1210121

Documentos

Células endoteliales de la vena safena humana (HSVEC)

Primary cell · Número de producto 300699

Venous endothelium for bypass graft research

€1,220.00sin impuestos ni gastos de envío

Personalización / Recomendaciones

Hecho por encargo
1

01Información general

Descripción

Primary Human Saphenous Vein Endothelial Cells (HSaVEC) are isolated from the saphenous vein and offer a venous endothelial model alongside HUVEC. They are used in research on atherosclerosis, leukocyte adhesion and the endothelial failure of coronary bypass vein grafts.

HSaVEC show the typical cobblestone morphology and express CD31 and VE-cadherin. As cells from adult vessels, they differ from fetal HUVEC: they are more sensitive to oxidized LDL, respond less strongly to cytokines and can present antigen to T cells, making them a closer model of adult venous endothelium.

Pañuelo de papel
Saphenous vein
Enfermedad
Normal saphenous vein endothelium (primary cells; non-tumorigenic)
Lugar de metástasis
Not applicable (normal, non-tumorigenic primary cell)
Aplicaciones
Adult endothelial model: ox-LDL, leukocyte adhesion, antigen presentation and tumor cell adhesion; Endothelial dysfunction in coronary bypass patients, screening of interventions; Mechanobiology: shear stress and arterial-level stretch in vein graft arterialization; Oxidative stress and mitophagy in vein graft failure; Insulin and IGF-1 receptor signaling in type 2 diabetes; Biomaterials: bioactive wound dressings for chronic wounds
Sinónimos
  • HSaVEC
  • HSVEC
  • Human saphenous vein endothelial cells
  • provitro 1210121

02Donante

Edad del donante
Lot-specific (see CoA)
Origen étnico
Lot-specific (see CoA)

03Clasificación

Organismo
Humano
Sexo
Específico de cada lote
Propiedades de crecimiento
Adherente
Situación respecto a los OMG
Sin OGM
Detalles sobre la presencia de OMG
No genetic modification; primary human endothelial cells isolated from saphenous vein tissue. Not transformed or immortalized.
Nivel de bioseguridad
1

04Características

Morfología
Cobblestone (endothelial)
Tipo de célula
Primary endothelial cells
Tumorigénico
No
Tiempo de duplicación
approx. 24 hours (under optimal EGM-2/EBM-2 conditions, Marelli-Berg et al. 2004)

05Manejo y cultivo

Medio de cultivo
Endothelial Cell Growth Medium
Atmósfera de incubación

37°C, 5% CO2, saturated humidity.

Suplementos
EGM-2-MV BulletKit supplements: hEGF, VEGF, hFGF-B, IGF-1, hydrocortisone, ascorbic acid, heparin, and 5% FBS (pre-formulated in EGM-2; no additional serum needed). Gelatin-coat culture vessels before seeding.
Reactivo de disociación
Subculture reagents as recommended on the certificate of analysis
Recubrimiento de frascos
0.1–0.2% gelatin coating required (incubate gelatin solution 30 min at 37°C, aspirate excess before seeding)
Subcultivo

Subculture the cells at about 75 % confluence. Denser cultures undergo irreversible contact inhibition and stop proliferating. Use the subculture reagents recommended on the certificate of analysis.

Relación de división
1 to 3
Densidad de siembra
More than 6,000 cells/cm²
Renovación de fluidos
24 hours after seeding, then every 48 to 72 hours
Recuperación tras la descongelación

Post-thaw viability ≥ 70 % viable cells. More than 80 % confluence within the expected recovery period.

Descongelación y cultivo
  1. Thaw the cryovial quickly in a 37 °C water bath, swirling gently. Just before the last ice has melted, move the vial to a laminar flow hood and decontaminate its outer surface.

  2. Transfer the cell suspension into a 15 ml centrifuge tube, add 10 ml of Endothelial Cell Growth Medium and centrifuge at 250 × g for 5 minutes.

  3. Remove the supernatant and resuspend the cell pellet in 10 ml of Endothelial Cell Growth Medium. Check cell number and viability.

  4. Divide the suspension between two 25 cm² culture flasks (5 ml each). Using two flasks reduces the risk of losing all cells if a passage fails.

  5. Incubate at 37 °C, 5 % CO₂ and saturated humidity, with the screw caps opened by half a turn for gas exchange.

  6. Change the medium after 24 hours to remove unattached cells, then every 48 to 72 hours, using pre-warmed medium only.

  7. Subculture the cells at about 75 % confluence. Denser cultures undergo irreversible contact inhibition and stop proliferating. Use the subculture reagents recommended on the certificate of analysis.

  8. Recommended seeding density: more than 6,000 cells/cm².

06Control de calidad y criopreservación

Esterilidad

Mycoplasma contamination is excluded by PCR.

To ensure there is no bacterial, fungal or yeast contamination, cultures are subjected to visual inspection.

Medio de congelación
As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability.
Condiciones de almacenamiento

For long-term preservation, store vials in liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable for up to one week only.

Condiciones de envío

Cryopreserved primary cells are shipped on dry ice. On receipt, check the cryovial for damage and transfer it without delay to appropriate storage.

07Expresión y susceptibilidad

Antígenos de superficie
CD31 (PECAM-1); VE-cadherin (CD144); von Willebrand factor (vWF); eNOS; HLA-DR (inducible); ICAM-1 (inducible); VCAM-1 (inducible); E-selectin (inducible); UEA-I lectin binding
Receptores expresados
VEGFR2 (KDR); VEGFR1; TIE-2; EGFR (low)

08Identificadores

Referencia
Human saphenous vein endothelial cells (HSVEC) (Cytion catalog number 300699)
N.º de identificación fiscal del NCBI
9606
Cellosaurus
Not assigned